Cutting-edge 360° management of ovarian cancer

Date: Thursday 22 May 2025
Time: 14:00-15:30 UTC
Description:
According to the World Cancer Research Fund, ovarian cancer is the eighth most common cancer among women worldwide with over 300,000 new cases detected every year. It remains one of the most challenging gynaecologic cancers to manage, often due to late-stage diagnosis and complex treatment pathways.
This webinar led by the FIGO Committee on Women's Cancer will describe a cutting-edge 360° approach to the diagnosis, management and treatment of ovarian cancer.
Leading global experts will discuss the latest recommendations and best practices on:
- Necessary diagnostics for detecting ovarian cancer
- Essentials of perioperative management
- Appropriate indications of neoadjuvant chemotherapy
- Debulking surgery to achieve complete tumour resection
- Patient tailored systemic and maintenance therapy according to biomarker profile
- Effective management of recurrent ovarian cancer
- Optimising care for patients in low resource settings
Health professionals will leave empowered with a multi-faceted approach to ovarian cancer management, supporting improved patient outcomes.
Language: English with live interpretation in French and Spanish.
Moderators
Prof Sarikapan Wilailak, FIGO Committee on Women's Cancer, Thailand
Prof Barbara Schmalfeldt, Vice Chair FIGO Committee on Women's Cancer, Germany
Speakers
Diagnostics, preoperative work-up, and indications for primary surgery or neoadjuvant therapy
Dr Ahmed Al-Niaimi, Memorial Sloan Kettering Cancer Center, United States
Staging and debulking surgery: step by step
Prof Christina Fotopoulou, Member FIGO Committee on Women's Cancer, United Kingdom
First line therapy and maintenance - Molecular diagnostics and biomarker testing
Prof Barbara Schmalfeldt, Vice Chair FIGO Committee on Women's Cancer, Germany
Management of recurrent ovarian cancer
Professor Nozomu Yanaihara, Associate member FIGO Committee on Women's Cancer, Japan
Management of ovarian cancer in low-resource setting
Dr Florencia Noll, International Gynecologic Cancer Society, Argentina